author-photo

Ian D. Davis

Monash University
Ludwig Institute for Cancer Research
Austin Hospital

466

Papers

12433

Citations

Citation Trend

Filter By

Papers (465) Sort By

Journal Conference Others

Abstract CT042: Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Updated overall survival (OS) from the randomized phase III study IMvigor130

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol

2021 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
UpFrontPSMA: A Randomised Phase 2 Study of Sequential 177 Lu-PSMA617 and Docetaxel versus Docetaxel in Metastatic Hormone-Naïve Prostate Cancer.

2021 BJUI
Show All
- Source
- Cite
- Save
Citations (7)
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501).

2021 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
Continuous bladder irrigation after transurethral resection of non-muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review.

2021 Anz Journal of Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Self-reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population-based registry.

2021 Psycho-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Targeted radioactive therapy for prostate cancer reply

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (0)
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.

2021 Internal Medicine Journal
Show All
- Source
- Cite
- Save
Citations (1)
UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Updated Overall Survival (OS) with atezolizumab (atezo) monotherapy vs. chemotherapy in untreated locally advanced or metastatic Urothelial Carcinoma (mUC) in the Phase III IMvigor130 study

2021
Show All
- Source
- Cite
- Save
Citations (0)